Toni Choueiri, Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Toni Choueiri, Dana-Farber Cancer Institute

Caption

Toni Choueiri, MD, and colleagues report they have found that treatment with three "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects. They added that the risk remains low, but should be taken into account by physicians when developing patients' treatment plans.

Credit

Sam Ogden

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.